Top

Clinical and Translational Oncology

Published in:

01-11-2001 | Notas Clínicas

Hepatitis fulminante tras suspensión del tratamiento inmunosupresor en un paciente con hepatitis crónica por virus de la hepatitis B y C

Authors: M.a José Safont Aguilera, Ana Albert Balaguer, Alfonso Berrocal Jaime, Natividad Martínez Barracloche

Published in: Clinical and Translational Oncology | Issue 6/2001

Title: Hepatitis fulminante tras suspensión del tratamiento inmunosupresor en un paciente con hepatitis crónica por virus de la hepatitis B y C
Authors: M.a José Safont Aguilera
Ana Albert Balaguer
Alfonso Berrocal Jaime
Natividad Martínez Barracloche
Publication date: 01-11-2001
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 6/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/BF02718426

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 6/2001

Cisplatino y vinorelbina en pacientes con cáncer de ovario epitelial como tratamiento de primera línea. Estudio piloto

Cáncer Rectal: Interrogantes Metodológicos

La astenia en el paciente con cáncer

Continued progress of preoperative therapy for rectal cancer

TRAIL/Apo-2L death signaling pathway and molecular targeting agents: implications for chemoresistance

Información

Keynote webinar | Spotlight on antibody–drug conjugates in cancer